Vidal Essebag
About
Vidal Essebag is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging.
According to data from OpenAlex, Vidal Essebag has authored 175 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 166 papers in Cardiology and Cardiovascular Medicine, 17 papers in Surgery and 10 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Vidal Essebag's work include Cardiac Arrhythmias and Treatments (131 papers), Atrial Fibrillation Management and Outcomes (102 papers) and Cardiac pacing and defibrillation studies (88 papers). Vidal Essebag is often cited by papers focused on Cardiac Arrhythmias and Treatments (131 papers), Atrial Fibrillation Management and Outcomes (102 papers) and Cardiac pacing and defibrillation studies (88 papers). Vidal Essebag collaborates with scholars based in Canada, United States and Italy. Vidal Essebag's co-authors include Louise Pilote, Atul Verma, Jeff S. Healey, Mark E. Josephson, David H. Birnie, Matthew R. Reynolds, George A. Wells, Cynthia A. Jackevicius, Riccardo Proietti and Hassan Behlouli and has published in prestigious journals such as New England Journal of Medicine, Circulation and SHILAP Revista de lepidopterología.
In The Last Decade
Vidal Essebag
167 papers receiving 5.0k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Vidal Essebag Canada | 34 | 4.6k | 505 | 447 | 409 | 300 | 175 | 5.2k | ||
| James V. Freeman United States | 28 | 3.2k 0.7× | 386 0.8× | 273 0.6× | 376 0.9× | 288 1.0× | 143 | 3.7k | ||
| Kumar Narayanan France | 29 | 4.7k 1.0× | 435 0.9× | 456 1.0× | 429 1.0× | 536 1.8× | 91 | 5.7k | ||
| Julie B. Shea United States | 18 | 3.8k 0.8× | 875 1.7× | 379 0.8× | 279 0.7× | 454 1.5× | 34 | 4.2k | ||
| Marco Proietti Italy | 39 | 3.8k 0.8× | 864 1.7× | 368 0.8× | 314 0.8× | 732 2.4× | 220 | 5.0k | ||
| Rui Providência United Kingdom | 33 | 4.7k 1.0× | 462 0.9× | 937 2.1× | 835 2.0× | 337 1.1× | 262 | 5.5k | ||
| Lars Frost Denmark | 37 | 2.7k 0.6× | 327 0.6× | 530 1.2× | 591 1.4× | 480 1.6× | 169 | 4.3k | ||
| Michele Massimo Gulizia Italy | 25 | 2.5k 0.5× | 206 0.4× | 700 1.6× | 255 0.6× | 237 0.8× | 242 | 3.0k | ||
| Cécile Laroche France | 38 | 4.7k 1.0× | 350 0.7× | 673 1.5× | 317 0.8× | 627 2.1× | 95 | 5.5k | ||
| Steven Borzak United States | 31 | 2.2k 0.5× | 333 0.7× | 707 1.6× | 574 1.4× | 202 0.7× | 82 | 3.2k | ||
| Deepak K. Gupta United States | 32 | 2.8k 0.6× | 403 0.8× | 692 1.5× | 591 1.4× | 333 1.1× | 110 | 4.0k |
Countries citing papers authored by Vidal Essebag
Since
Specialization
Citations
This map shows the geographic impact of Vidal Essebag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vidal Essebag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vidal Essebag more than expected).
Fields of papers citing papers by Vidal Essebag
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Vidal Essebag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vidal Essebag. The network helps show where Vidal Essebag may publish in the future.
Co-authorship network of co-authors of Vidal Essebag
This figure shows the co-authorship network connecting the top 25 collaborators of Vidal Essebag. A scholar is included among the top collaborators of Vidal Essebag based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vidal Essebag. Vidal Essebag is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Nery, Pablo B., George A. Wells, Anthony Tang, et al.. (2025). Catheter Ablation vs Sotalol or Amiodarone for Ventricular Tachycardia. Journal of the American College of Cardiology. 87(2). 157–168.
2.
Joza, Jacqueline, Peter Tai, Vidal Essebag, et al.. (2025). Implementation of lead V8 as a simple non-invasive tool to improve patient selection in CRT and guide LV lead placement. EP Europace. 27(9).
3.
Joza, Jacqueline, Ahmed AlTurki, Paula Sánchez-Somonte, et al.. (2024). Cardioneuroablation as a strategy to prevent pacemaker implantation in young patients with vasovagal syncope. IJC Heart & Vasculature. 51. 101360–101360.
4.
Verma, Atul, Vidal Essebag, Petr Neužil, et al.. (2024). Cryocure-VT: the safety and effectiveness of ultra-low-temperature cryoablation of monomorphic ventricular tachycardia in patients with ischaemic and non-ischaemic cardiomyopathies. EP Europace. 26(4).
5.
AlTurki, Ahmed, Jacqueline Joza, Riccardo Proietti, et al.. (2024). Meta‐analysis evaluating apixaban in patients with atrial fibrillation and end‐stage renal disease requiring dialysis. Journal of Arrhythmia. 40(3). 440–447.
6.
Samuel, Michelle, Jeff S. Healey, Isabelle Nault, et al.. (2023). Ventricular Tachycardia and ICD Therapy Burden With Catheter Ablation Versus Escalated Antiarrhythmic Drug Therapy. JACC. Clinical electrophysiology. 9(6). 808–821.
7.
Joza, Jacqueline, Girish M. Nair, David H. Birnie, et al.. (2023). High‐power short‐duration versus low‐power long‐duration ablation for pulmonary vein isolation: A substudy of the AWARE randomized controlled trial. Journal of Cardiovascular Electrophysiology. 35(1). 136–145.
8.
Samuel, Michelle, Michał Abrahamowicz, Jacqueline Joza, Vidal Essebag, & Louise Pilote. (2020). Population-Level Sex Differences and Predictors for Treatment With Catheter Ablation in Patients With Atrial Fibrillation and Heart Failure. CJC Open. 2(3). 85–93.
9.
AlTurki, Ahmed, Jacqueline Joza, Martin Bernier, Riccardo Proietti, & Vidal Essebag. (2020). Catheter Ablation of Atrial Fibrillation: Current and Evolving Indications. Canadian Journal of Cardiology. 36(10). 1685–1689.
10.
AlTurki, Ahmed, Martin Bernier, Daniel García, et al.. (2020). Optimization of Chronic Cardiac Resynchronization Therapy Using Fusion Pacing Algorithm Improves Echocardiographic Response. CJC Open. 2(2). 62–70.
11.
Samuel, Michelle, Michał Abrahamowicz, Jacqueline Joza, et al.. (2020). Long-term effectiveness of catheter ablation in patients with atrial fibrillation and heart failure. EP Europace. 22(5). 739–747.
12.
AlTurki, Ahmed, Riccardo Proietti, Paul Dorian, et al.. (2018). Meta-Analysis Comparing Neurohumoral Antagonist Use in Patients ≥75 Years Versus <75 Years Receiving Cardiac Resynchronization Therapy. The American Journal of Cardiology. 121(8). 975–980.
13.
Verma, Atul, Andrew C.T. Ha, Paulus Kirchhof, et al.. (2017). The Optimal Anti-Coagulation for Enhanced-Risk Patients Post–Catheter Ablation for Atrial Fibrillation (OCEAN) trial. American Heart Journal. 197. 124–132.
14.
Zhan, Yang, Jacqueline Joza, Michelle Samuel, et al.. (2017). Assessment and Management of the Left Atrial Appendage Thrombus in Patients With Nonvalvular Atrial Fibrillation. Canadian Journal of Cardiology. 34(3). 252–261.
15.
Kuś, Teresa, et al.. (2016). Simple risk stratification score for prognosis of syncope. Journal of Interventional Cardiac Electrophysiology. 47(2). 153–161.
16.
Patel, Ashish, Mary Tan, Paul Angaran, et al.. (2014). Risk Stratification and Stroke Prevention Therapy Care Gaps in Canadian Atrial Fibrillation Patients (from the Co-ordinated National Network to Engage Physicians in the Care and Treatment of Patients With Atrial Fibrillation Chart Audit). The American Journal of Cardiology. 115(5). 641–646.
17.
Proietti, Riccardo, David Birnie, Jeff S. Healey, Atul Kumar Verma, & Vidal Essebag. (2013). L’elettrostimolazione cardiaca in corso di terapia anticoagulante orale: lo studio BRUISE CONTROL. Giornale italiano di cardiologia. 14(11). 724–5.
18.
Tsadok, Meytal Avgil, Cynthia A. Jackevicius, Vidal Essebag, et al.. (2012). Rhythm Versus Rate Control Therapy and Subsequent Stroke or Transient Ischemic Attack in Patients With Atrial Fibrillation. Circulation. 126(23). 2680–2687.
19.
Kotowycz, Mark A., Kristian B. Filion, Jacqueline Joza, et al.. (2011). In-Hospital Management of Atrial Fibrillation: The CHADS2 Score Predicts Increased Cost. Canadian Journal of Cardiology. 27(4). 506–513.
20.
Essebag, Vidal, Tom Hadjis, Robert W. Platt, Michał Abrahamowicz, & Louise Pilote. (2004). Effect of Amiodarone Dose on the Risk of Permanent Pacemaker Insertion. Pacing and Clinical Electrophysiology. 27(11). 1519–1525.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by James V. Freeman Breakdown of academic impact, for papers by Kumar Narayanan Breakdown of academic impact, for papers by Julie B. Shea Breakdown of academic impact, for papers by Marco Proietti Breakdown of academic impact, for papers by Rui Providência Breakdown of academic impact, for papers by Lars Frost Breakdown of academic impact, for papers by Michele Massimo Gulizia Breakdown of academic impact, for papers by Cécile Laroche Breakdown of academic impact, for papers by Steven Borzak Breakdown of academic impact, for papers by Deepak K. Gupta